FDA Inspection 969771 — XTANT Medical Holdings, Inc

XTANT Medical Holdings, Inc — FEI 3005031160

The FDA completed an inspection of XTANT Medical Holdings, Inc on May 18, 2016 in Belgrade, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Belgrade, MT (United States)